KEY WORDS group B streptococcus; neonatal sepsis; pregnancy he risk of perinatal genital carriage of group B streptococcus (GBS) ranges from about 10-30%, depending on the manner in which screening cultures are performed and the populations screened. 1, 2 The risk of vertical transmission of GBS from such mothers yielding early-onset neonatal sepsis is about .5%, and the risk of mortality from this sepsis is currently about 15%. [3] [4] [5] [6] The overall risk of neonatal mortality from GBS sepsis is therefore about 1--4 per 10,000 births. The Centers for Disease Control and Prevention (CDC) has recommended either one of two protocols for the prevention of this serious outcome, 7 though no randomized studies exist which show the two protocols to be equivalent in efficacy. Numerous studies have shown the efficacy of intrapartum chemoprophylaxis in preventing neonatal GBS, 4, 8, 9 Table 1 ). In addition, these same records were reviewed to determine the length of time between the admission of the patient to the labor and delivery unit and delivery.
RESULTS
The 30 maternal cases that were delivered in our institution from 1992 to 1996 in which early-onset 26 
aGBS, group B streptococcus. bND, Not determined.
CNeonatal death.
pected for every 100,000 patients treated with penicillin. 14,1s Extrapolating from this estimate, it appears that six women could die annually if the CDC's recommendation were followed. It should be further emphasized that the fetus can also be adversely affected in anaphylactic reactions, as has been reported. 16, 17 Additionally, the volume of antibiotic use recommended by such a protocol will undoubtedly have an impact on the emergence of resistant bac- 
